Enhancement of innate immunity with granulocyte colony-stimulating factor did not mitigate disease in pigs infected with a highly pathogenic Chinese PRRSV strain.

[1]  M. Luo,et al.  Emergence of a novel highly pathogenic porcine reproductive and respiratory syndrome virus in China , 2017, Transboundary and emerging diseases.

[2]  M. Murtaugh,et al.  Emergence of a virulent porcine reproductive and respiratory syndrome virus in vaccinated herds in the United States. , 2015, Virus research.

[3]  R. She,et al.  Comparative Respiratory Pathogenicity and Dynamic Tissue Distribution of Chinese Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus and its Attenuated Strain in Piglets. , 2015, Journal of comparative pathology.

[4]  T. Terhune,et al.  Efficacy of polyethylene glycol-conjugated bovine granulocyte colony-stimulating factor for reducing the incidence of naturally occurring clinical mastitis in periparturient dairy cows and heifers. , 2015, American journal of veterinary research.

[5]  W. Nauseef,et al.  Neutrophils at work , 2014, Nature Immunology.

[6]  Philip A. Kramer,et al.  Bioenergetics and the Oxidative Burst: Protocols for the Isolation and Evaluation of Human Leukocytes and Platelets , 2014, Journal of visualized experiments : JoVE.

[7]  K. Lager,et al.  Chinese and Vietnamese strains of HP-PRRSV cause different pathogenic outcomes in United States high health swine. , 2013, Virology.

[8]  K. Lager,et al.  Porcine granulocyte-colony stimulating factor (G-CSF) delivered via replication-defective adenovirus induces a sustained increase in circulating peripheral blood neutrophils. , 2013, Biologicals : journal of the International Association of Biological Standardization.

[9]  C. Murphy,et al.  An Intact Sialoadhesin (Sn/SIGLEC1/CD169) Is Not Required for Attachment/Internalization of the Porcine Reproductive and Respiratory Syndrome Virus , 2013, Journal of Virology.

[10]  James Kliebenstein,et al.  Assessment of the economic impact of porcine reproductive and respiratory syndrome virus on United States pork producers , 2013, Journal of Swine Health and Production.

[11]  T. Nicholson,et al.  Experimental infection of United States swine with a Chinese highly pathogenic strain of porcine reproductive and respiratory syndrome virus , 2012, Virology.

[12]  G. Tong,et al.  Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus, Asia , 2011, Emerging infectious diseases.

[13]  V. Franceschi,et al.  Cytokine expression, glucocorticoid and growth hormone changes after porcine reproductive and respiratory syndrome virus (PRRSV-1) infection in vaccinated and unvaccinated naturally exposed pigs. , 2011, Comparative immunology, microbiology and infectious diseases.

[14]  Xuehui Cai,et al.  Secondary infection with Streptococcus suis serotype 7 increases the virulence of highly pathogenic porcine reproductive and respiratory syndrome virus in pigs , 2010, Virology Journal.

[15]  Lei Zhou,et al.  The 30-Amino-Acid Deletion in the Nsp2 of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus Emerging in China Is Not Related to Its Virulence , 2009, Journal of Virology.

[16]  S. Yuan,et al.  An infectious cDNA clone of a highly pathogenic porcine reproductive and respiratory syndrome virus variant associated with porcine high fever syndrome. , 2008, The Journal of general virology.

[17]  Xinglong Wang,et al.  Emergence of a highly pathogenic porcine reproductive and respiratory syndrome virus in the Mid-Eastern region of China. , 2007, Veterinary journal.

[18]  H. Qiu,et al.  Highly Pathogenic Porcine Reproductive and Respiratory Syndrome, China , 2007, Emerging infectious diseases.

[19]  Di Liu,et al.  Emergence of Fatal PRRSV Variants: Unparalleled Outbreaks of Atypical PRRS in China and Molecular Dissection of the Unique Hallmark , 2007, PloS one.

[20]  M. E. Clark,et al.  Effect of Bovine Granulocyte Colony-Stimulating Factor on the Development of Pneumonia Caused by Mannheimia haemolytica , 2004, Veterinary pathology.

[21]  A. Amonsin,et al.  Genetics and geographical variation of porcine reproductive and respiratory syndrome virus (PRRSV) in Thailand. , 2004, Veterinary microbiology.

[22]  P. Halbur,et al.  Effects of different us isolates of porcine reproductive and respiratory syndrome virus (PRRSV) on blood and bone marrow parameters of experimentally infected pigs , 2002, Veterinary Record.

[23]  D. Lauffenburger,et al.  Rational cytokine design for increased lifetime and enhanced potency using pH-activated “histidine switching” , 2002, Nature Biotechnology.

[24]  L. R. Hill,et al.  Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  B. Lord,et al.  Kinetics of neutrophil production in normal and neutropenic animals during the response to filgrastim (r-metHu G-CSF) or filgrastim SD/01 (PEG-r-metHu G-CSF). , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  E. Thacker,et al.  Differential production of proinflammatory cytokines: in vitro PRRSV and Mycoplasma hyopneumoniae co-infection model. , 2001, Veterinary immunology and immunopathology.

[27]  M. Palmer,et al.  Effects of intranasal inoculation with Bordetella bronchiseptica, porcine reproductive and respiratory syndrome virus, or a combination of both organisms on subsequent infection with Pasteurella multocida in pigs. , 2001, American journal of veterinary research.

[28]  P. Halbur,et al.  Effect of porcine reproductive and respiratory syndrome virus (PRRSV) (isolate ATCC VR-2385) infection on bactericidal activity of porcine pulmonary intravascular macrophages (PIMs): in vitro comparisons with pulmonary alveolar macrophages (PAMs). , 1997, Veterinary immunology and immunopathology.

[29]  S. Goyal,et al.  Experimental Porcine Reproductive and Respiratory Syndrome Virus Infection in One-, Four-, and 10-Week-Old Pigs , 1994, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[30]  J. Cullor,et al.  Immunobiology of hematopoietic colony-stimulating factors: potential application to disease prevention in the bovine. , 1991, Journal of dairy science.

[31]  J. Goff,et al.  Effects of granulocyte colony-stimulating factor administration to periparturient cows on neutrophils and bacterial shedding. , 1991, Journal of dairy science.

[32]  J. Watts,et al.  Effects of recombinant granulocyte colony-stimulating factor on Staphylococcus aureus mastitis in lactating dairy cows. , 1989, Journal of dairy science.

[33]  J. Gabrilove,et al.  Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates , 1987, The Journal of experimental medicine.

[34]  K. Zsebo,et al.  In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[35]  P. Clements,et al.  Human lymphocyte subpopulations. Effect of corticosteroids. , 1974, The Journal of clinical investigation.

[36]  J. Guitian,et al.  Emergence of highly pathogenic porcine reproductive and respiratory syndrome (HP-PRRS) in medium-scale swine farms in southeastern Cambodia. , 2015, Preventive veterinary medicine.

[37]  M. Takagi,et al.  Highly Pathogenic Porcine Reproductive and Respiratory Syndrome , 2011 .

[38]  J. Domínguez,et al.  Phenotypic and functional characterization of porcine granulocyte developmental stages using two new markers. , 2007, Developmental and comparative immunology.

[39]  E. Thacker,et al.  Interleukin-10, interleukin-12, and interferon-gamma levels in the respiratory tract following mycoplasma hyopneumoniae and PRRSV infection in pigs. , 2003, Viral immunology.

[40]  M. Piccart,et al.  A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.